tiprankstipranks
Trending News
More News >
Keymed Biosciences, Inc. (HK:2162)
:2162
Hong Kong Market

Keymed Biosciences, Inc. (2162) Balance Sheet

Compare
1 Followers

Keymed Biosciences, Inc. Balance Sheet

Keymed Biosciences, Inc.'s total assets for Q2 2025 were ¥4.63B, an increase of 22.95% from the previous quarter. HK:2162 total liabilities were ¥1.44B for the fiscal quarter, a 11.17% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Assets
¥ 3.77B¥ 3.88B¥ 3.93B¥ 3.93B¥ 529.95M
Total Liabilities
¥ 1.29B¥ 896.11M¥ 593.10M¥ 289.07M¥ 1.62B
Total Equity Gross Minority
¥ 2.48B¥ 2.99B¥ 3.34B¥ 3.65B¥ -1.09B
Other Metrics
Currency in CNY

Keymed Biosciences, Inc. Debt to Assets